JPMorgan Chase & Co. reaffirmed their top pick rating on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Get Rating) in a report issued on Tuesday, The Fly reports. Several other research analysts have also recently weighed in on XENE. Needham & Company LLC reissued a buy rating and issued a $50.00 price objective on shares of […]
Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) saw an uptick in trading volume on Monday . 333,165 shares changed hands during trading, a decline of 15% from the previous session’s volume of 392,663 shares.The stock last traded at $39.87 and had previously closed at $39.39. Analysts Set New Price Targets Several research firms […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.